Log In
BCIQ
Print this Print this
 

KEA-0477

  Manage Alerts
Collapse Summary General Information
Company Kissei Pharmaceutical Co. Ltd.
DescriptionSelective prostaglandin EP1 receptor antagonist
Molecular Target Prostaglandin E1 (PGE1) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today